Trade AEON stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
AEON Biopharma, Inc. (AEON) is trading at US$0.29, up 25.54% today as of Sep 10, 16:00 EDT. The company has a market capitalisation of US$9.58M. Over the past 52 weeks, AEON has traded between US$0.18 and US$1.45. On Syfe you can trade AEON with $0 commission and add it to your watchlist.
| Previous close | US$0.23 |
|---|---|
| Market cap | US$9.58M |
| 52-week range | US$0.18 – US$1.45 |
| Volume | 199.24M |
| Exchange | US |
Add to Watchlist
Set Price Alert
AEON Biopharma, Inc.
AEON Biopharma, Inc. is a biopharmaceutical company, which engages in the business of developing proprietary botulinum toxin complex, ABP-450 injection, for debilitating medical conditions. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Irvine, CA.
Year: 2023
Aeon Biopharma Prices $13.8 Million Underwritten Public Offering
Jul 14, 1:22 PM · MT Newswires
AEON Biopharma, Inc. (AEON) stock is trading at US$0.29, +25.54% from the previous close of US$0.23.
The market cap for AEON Biopharma, Inc. (AEON) stock is approximately US$9.58M.
The 52-week high for AEON Biopharma, Inc. (AEON) stock is US$1.45.
The 52-week low for AEON Biopharma, Inc. (AEON) stock is US$0.18.
AEON Biopharma, Inc. (AEON) does not currently pay a dividend.
Stay on top of AEON
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
